Astrazeneca Pharma India rises on LOI with Reliance's Strand Life Sciences
BUZZ-Astrazeneca Pharma India rises on LOI with Reliance's Strand Life Sciences ** Shares of Astrazeneca Pharma India ASTR.NS rise 2.4% to 6,182 rupees
** Pharmaceutical co signs letter of intent (LOI) with Strand Life Sciences, a subsidiary of Reliance Industries RELI.NS
** ASTR signs LOI to explore opportunities to collaborate in healthcare in India
** Stock down 32.44% YTD
(Reporting by Anushka Rajvedi in Bengaluru)
((mailto: anushka.rajvedi@thomsonreuters.com))
Recent news on Reliance Industries
See all newsCorrected: India's Reliance plans to invest about $1.6 billion to build new biogas plants
Astrazeneca Pharma India rises on LOI with Reliance's Strand Life Sciences
India's Clean Max plans $5.3 billion clean energy investment to power AI computing facility
GAIL, farm cooperative sign pact to explore $1.6 billion Andhra Pradesh urea project
India's Reliance plans $4.6 billion coal-to-gas project, document shows (updated)